Endometriosis Robotic Excision With Fertility Preservation: Treatment Announced

Lotus Endometriosis Institute has announced that it will be offering minimally invasive robotic excision for stage 3 and 4 endometriosis. Techniques will focus on fertility preservation, enabling patients to consider pregnancy in the future.

Arroyo Grande, United States, September 21, 2026 /PressCable/ -- Lotus Endometriosis Institute has announced that it is offering robotic excision for stage 3 and 4 endometriosis, which include severe cases with bowel, bladder, ureter, and diaphragm involvement. This minimally invasive procedure focuses on improving recovery time and preserving fertility in patients, allowing them to consider future pregnancies.

For more information, please visit https://lotusendo.com/services/surgery-and-advanced-excision

According to the World Health Organization, endometriosis affects roughly 10% of reproductive-age women, transgender men, and non-binary individuals worldwide - an equivalent of 190 million people. The disease occurs when endometrial tissue grows outside the uterus, resulting in significant pain, inflammation, and scarring. The causes of endometriosis are unknown, and there are currently no treatments that can relieve symptoms; only surgery can definitively diagnose endometriosis, but the outcome of the procedure is dependent on how much of the disease is successfully removed.

To treat endometriosis, Lotus Endometriosis Institute exclusively uses specialized robotic excision, an advanced form of minimally invasive surgery. The procedure is carried out using the DaVinci robotic system and high-definition 3D optics that can magnify anatomy up to 10 times - technology that results in smaller incisions and allows for greater precision and detection of flat lesions. Lotus Endometriosis Institute adds that this method also targets endometriosis at the root, while traditional procedures, like ablation, may leave some disease behind, necessitating repeat surgeries.

“Unlike standard laparoscopy, where ‘straight stick’ instruments are limited to grasping, cutting, pushing, and pulling, robotic instruments move with natural, wrist-like motions. For patients, this often translates into fewer accidental injuries and less strain on the body,” explains a spokesperson for the company.

Lotus Endometriosis Institute also acknowledges that endometriosis can present differently in every patient. Consequently, its multidisciplinary team of surgeons adapts its approach to each case to account for fertility preservation, genetic risk of malignant degeneration, and other organ involvement. Regardless of procedure complexity, patients generally do not need narcotic medications and can resume work or daily activities within two to three weeks.

Surgeries are directed by Dr. Steve Vasilev, quadruple board-certified gynecologic oncologist with over 30 years of experience in surgical leadership. He and his team specialize in minimally invasive gynecologic surgery (MIGS) with a focus on endometriosis, ensuring patients receive tailored care for their condition.

More information is available at https://lotusendo.com/services/surgery-and-advanced-excision

Contact Info:
Name: Dr. Steven Vasilev
Email: Send Email
Organization: Lotus Endometriosis Institute
Address: 154 Traffic Way, Arroyo Grande, CA 93420, United States
Website: https://lotusendo.com

Source: PressCable

Release ID: 89203969

If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.